External preparation for skin
A skin preparation with niacinamide and liposome-encapsulated ingredients like D-pantothenyl alcohol and pine bark extract addresses the lack of moisturizing effect in existing formulations, offering improved skin hydration and firmness.
Patent Information
- Application Number
- JP2023083921
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-22
- Publication Date
- 2024-12-04
AI Technical Summary
Existing skin preparations using niacinamide lack an excellent moisturizing effect and feeling of use.
A skin external preparation containing niacinamide, D-pantothenyl alcohol, 3-O-ethyl ascorbic acid, pine bark extract, glutathione or ceramides, and hydrogenated soybean phospholipids encapsulated in liposomes, optionally with additional antioxidants, moisturizers, anti-inflammatory agents, whitening agents, and peeling agents, to enhance moisturizing effect and skin firmness.
The composition provides improved moisturizing effect, smoothness during application, and enhanced skin firmness after use, with increased moisture content in the stratum corneum.
Smart Images

Figure 2024167684000001 
Figure 2024167684000002 
Figure 2024167684000003
Abstract
Description
[Technical field]
[0001] The present invention relates to an external preparation for skin. [Background technology]
[0002] Conventionally, various active ingredients have been proposed for topical skin preparations, and cosmetics and pharmaceuticals containing these active ingredients are on the market. Examples of such active ingredients include cell activating ingredients such as α-hydroxycarboxylic acids; extracellular matrix ingredients such as collagen, elastin, hyaluronic acid or its salts; and moisturizing agents such as urea. In addition, antioxidants and moisturizing agents derived from plants have also been proposed. For example, Patent Document 1 describes that a skin topical preparation containing niacinamide and an extract of the fruit of Ziziphus jujuba of the Rhamnaceae family as active ingredients can improve the barrier function of the skin, prevent and improve dry skin, and prevent and improve thinning of the skin, and also describes an essence containing niacinamide and ceramide (e.g., Patent Document 1). Furthermore, Patent Document 2 describes an external skin preparation for improving wrinkles, which contains D-pantothenyl alcohol and niacinamide. [Prior art documents] [Patent documents]
[0003] [Patent Document 1] JP 2022-163643 A [Patent Document 2] Patent Publication No. 2021-063076 Summary of the Invention [Problem to be solved by the invention]
[0004] However, no topical skin preparation using niacinamide that has excellent moisturizing effect and a good feeling when used has been obtained. The present invention aims to provide an external skin preparation which uses niacinamide and has excellent moisturizing effect and feeling of use. [Means for solving the problem]
[0005] The present invention provides the following [1] to [4]. [1] A skin topical preparation comprising the following components (A), (B), (C), (D), (E) and (F) of niacinamide, wherein (C), (D) and (E) are encapsulated in liposomes containing (F) hydrogenated soybean phospholipid. (A) Niacinamide. (B) D-pantothenyl alcohol. (C) 3-O-ethyl ascorbic acid. (D) Pine bark extract. (E) At least one selected from glutathione and ceramides. (F) Hydrogenated soybean phospholipid. [2] The topical skin preparation according to [1], further comprising (G) at least one selected from antioxidants, moisturizing agents, anti-inflammatory agents, whitening agents, vitamins, and peeling agents. [3] The skin external preparation according to [2], wherein (G) is one or more selected from the group consisting of bilberry leaf extract, astaxanthin, Centella asiatica leaf extract, bisglyceryl ascorbic acid, tocopherol and lactic acid. [4] (A) The topical skin preparation according to any one of [1] to [3], wherein the content of niacinamide in the composition is 5% by mass or more. Effect of the Invention
[0006] The present invention can provide an external skin preparation using niacinamide, which has excellent moisturizing effect and excellent usability. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0007] The preferred embodiments of the present invention will be described below. In the present invention, the "feel when used" refers to smoothness when applied and improvement in skin clarity and firmness after use. In the present invention, the moisturizing effect refers to the effect of increasing the moisture content of the stratum corneum. The present invention provides a skin external preparation which is a composition containing the above (A), (B), (C), (D), (E) and (F), and in which (C), (D) and (E) are encapsulated in liposomes containing (F) hydrogenated soybean phospholipid. A liposome is a closed vesicle formed by a lipid bilayer membrane containing a lipid such as lecithin, and has an aqueous phase (internal aqueous phase) within the space of the closed vesicle. In many cases, liposomes exist in a dispersed state in an aqueous solution (external aqueous phase) outside the closed vesicle. As used herein, the expression "a given component is encapsulated in a liposome" means that the component is not present only in the external aqueous phase, but that at least a portion of the component is present in the membrane of the liposome or in the internal aqueous phase within the liposome.
[0008] (A) Niacinamide The skin external preparation of the present invention contains niacinamide (A) in the presence of (B) to (F), thereby enhancing the moisturizing effect and improving the feeling of use, such as smoothness when applied and firmness of the skin after use. Niacinamide is also known as nicotinamide. Niacinamide may be an extract extracted from natural products such as rice bran, a synthetic product synthesized by a known manufacturing method, or a commercially available product may be obtained and used. Specifically, nicotinamide listed in the 17th revised Japanese Pharmacopoeia may be used.
[0009] (A) Niacinamide may be encapsulated in a liposome containing (F) hydrogenated soybean phospholipid, or may be present in the external aqueous phase outside the liposome.
[0010] From the viewpoint of further improving the effect of excellent moisturizing effect, smoothness during application, and excellent skin firmness after use, (A) niacinamide is preferably contained in the skin topical preparation of the present invention at 1% by mass or more, more preferably at 2% by mass or more.In particular, from the viewpoint of improving moisturizing effect, (A) niacinamide is further preferably contained in the skin topical preparation at 3% by mass or more, particularly preferably at 4% by mass or more, and most preferably at 5% by mass or more.The upper limit of the amount of (A) niacinamide in the skin topical preparation is preferably 15% by mass or less, more preferably 12% by mass or less, and most preferably 10% by mass or less, in order to obtain a skin topical preparation with excellent usability.
[0011] (B) D-Pantothenyl alcohol The skin topical preparation of the present invention contains (B) D-pantothenyl alcohol in the presence of (A), (C) to (F), and thereby has excellent moisturizing effect, smoothness upon application, and excellent skin transparency and firmness after use. As D-pantothenyl alcohol, commercially available products can be used, and specifically, D-pantothenyl alcohol listed in the Quasi-Drug Raw Materials Standards 2021 can be used.
[0012] In the skin external preparation of the present invention, the amount of (B) D-pantothenyl alcohol is preferably 0.01% by mass or more in the skin external preparation, in order to make the effect of the present invention by using (B) D-pantothenyl alcohol excellent. From this viewpoint, the amount of (B) D-pantothenyl alcohol in the skin external preparation is more preferably 0.05% by mass or more, and particularly preferably 0.1% by mass or more. From the same viewpoint, the amount of (B) D-pantothenyl alcohol in the skin external preparation is preferably 20% by mass or less, more preferably 10% by mass or less, and particularly preferably 5% by mass or less.
[0013] (B) D-pantothenyl alcohol may be encapsulated in a liposome containing (F) hydrogenated soybean phospholipid, or may be present in the external aqueous phase outside the liposome.
[0014] In the skin external preparation of the present invention, the amount of D-pantothenyl alcohol (B) is preferably 0.1 to 100 parts by mass relative to 100 parts by mass of niacinamide (A), in order to further improve the effects of the present invention. From this viewpoint, the amount of D-pantothenyl alcohol (B) is more preferably 1 part by mass or more, and particularly preferably 5 parts by mass or more, relative to 100 parts by mass of niacinamide (A). From the viewpoint of further improving the effects of the present invention, the amount of D-pantothenyl alcohol (B) is more preferably 80 parts by mass or less, and particularly preferably 50 parts by mass or less, relative to 100 parts by mass of niacinamide (A).
[0015] (C) 3-O-Ethyl Ascorbic Acid The topical skin preparation of the present invention contains (C) 3-O-ethyl ascorbic acid in the presence of (A), (B), and (D) to (F), and thereby exerts the effects of enhancing the moisturizing effect, as well as improving the smoothness upon application and the firmness of the skin after use.
[0016] 3-O-ethyl ascorbic acid is not particularly limited as long as it is used as an ingredient of a skin external preparation in a pharmaceutical product, a quasi-drug product, or a cosmetic product. A synthetic product can be used as 3-O-ethyl ascorbic acid. The synthetic method includes a method of ethoxylating the hydroxyl group at the 3-position of ascorbic acid, which is described in, for example, JP-A-8-134055. A commercially available product can also be used as 3-O-ethyl ascorbic acid.
[0017] (C) 3-O-ethyl ascorbic acid is encapsulated in liposomes containing (F) hydrogenated soybean phospholipids. This improves the stability of (C) 3-O-ethyl ascorbic acid in the skin topical preparation of the present invention, thereby enhancing the moisturizing effect, as well as the effect of improving smoothness when applied and firmness of the skin after use. It is possible to confirm that (C) component is encapsulated in liposomes containing (F) hydrogenated soybean phospholipids by performing a confirmation test on each component after removing the liposomes from the skin topical preparation. The presence of (C) component in the liposomes can be confirmed, for example, by removing the external aqueous phase outside the liposomes by gel filtration chromatography, followed by liquid chromatography or the like.
[0018] In the skin external preparation of the present invention, the amount of (C) 3-O-ethyl ascorbic acid is preferably 0.00001% by mass or more in the skin external preparation, in order to make the effect of the present invention by using (C) 3-O-ethyl ascorbic acid excellent. From this viewpoint, the amount of (C) 3-O-ethyl ascorbic acid in the skin external preparation is more preferably 0.00005% by mass or more, and particularly preferably 0.0001% by mass or more. Also, from the same viewpoint, the amount of (C) 3-O-ethyl ascorbic acid in the skin external preparation is preferably 10% by mass or less, more preferably 5% by mass or less, and particularly preferably 1% by mass or less.
[0019] In the skin external preparation of the present invention, the amount of (C) 3-O-ethyl ascorbic acid is preferably 0.0001 to 50 parts by mass relative to 100 parts by mass of (A) niacinamide, in order to further improve the effects of the present invention. From this viewpoint, the amount of (C) 3-O-ethyl ascorbic acid is more preferably 0.001 parts by mass or more relative to 100 parts by mass of (A) niacinamide, and particularly preferably 0.005 parts by mass or more. From the viewpoint of further improving the effects of the present invention, the amount of (C) 3-O-ethyl ascorbic acid is more preferably 30 parts by mass or less relative to 100 parts by mass of (A) niacinamide, and particularly preferably 10 parts by mass or less.
[0020] (D) Pine bark extract The topical skin preparation of the present invention contains (D) pine bark extract in the presence of (A) to (C), (E) and (F), thereby effectively enhancing the moisturizing effect, as well as improving the smoothness upon application and the firmness of the skin after use.
[0021] In the present invention, the pine tree bark extract (D) can be derived from plants belonging to the order Pinales, such as French maritime pine, Japanese larch, Japanese black pine, Japanese red pine, Japanese white pine, Korean pine, Japanese stone pine, Japanese stone pine, Japanese stone pine, Japanese white pine, and Aneda in the Quebec region of Canada, but is not limited thereto. Among these, French maritime pine (Pinus pinaster), which is a maritime pine growing on the Atlantic coast of southern France, is preferred, because it has been confirmed to be safe as a skin external preparation and contains a high concentration of antioxidants such as catechin.
[0022] (D) Pine bark extract is obtained by extracting pine bark with a solvent. Examples of the solvent include water, organic solvents, and water-containing organic solvents (water-containing alcohols such as water-containing ethanol). The organic solvent used for the extraction is usually an organic solvent that is acceptable for extracting natural product components, and examples of the organic solvent include monohydric alcohols such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, and 2-butanol, glycols such as propylene glycol, polyhydric alcohols such as glycerin, butane, acetone, hexane, cyclohexane, water-containing ethanol, water-containing propylene glycol, ethyl methyl ketone, methyl acetate, ethyl acetate, diethyl ether, dichloromethane, edible oils and fats, 1,1,1,2-tetrafluoroethane, and 1,1,2-trichloroethene. These solvents can be used alone or in combination of two or more. The temperature during the extraction can be appropriately adjusted from room temperature to a temperature below the boiling point of the extraction solvent. In the present invention, from the viewpoint of efficiently improving the moisturizing effect, smoothness upon application, and firmness of the skin after use, at least one selected from water, aqueous ethanol, and aqueous propylene glycol is preferably used.
[0023] The extraction method is not particularly limited as long as it is a method that is generally acceptable for extracting natural product components, and examples of the extraction method include solid-liquid extraction methods such as heating extraction and supercritical fluid extraction. The heating extraction method is, for example, a method in which a test substance is contacted with a solvent and treated at a temperature below the boiling point of the solvent to extract the components contained in the test substance into the solvent. The reflux extraction method may be used. The supercritical fluid extraction method is, for example, a method in which extraction is performed using a supercritical fluid, which is a fluid in a state exceeding the gas-liquid critical point (critical temperature, critical pressure) of a substance. Examples of supercritical fluids include carbon dioxide, ethylene, propane, and nitrous oxide (laughing gas). As the supercritical fluid extraction method, an entrainer addition method may be performed. In this method, for example, ethanol, propanol, n-hexane, acetone, toluene, other aliphatic lower alcohols, aliphatic hydrocarbons, aromatic hydrocarbons, and ketones are added to the extraction fluid at about 2 to 20 W / V%, and the supercritical fluid extraction is performed using this fluid. In addition to the above-mentioned extraction methods, extraction from pine bark may be performed by a liquid carbon dioxide batch method, a liquid carbon dioxide reflux method, a supercritical carbon dioxide reflux method, etc. In the supercritical fluid extraction method, an extraction step in which the target component is extracted by a supercritical fluid and a separation step in which the target component is separated from the supercritical fluid are performed. In the separation step, extraction and separation by pressure change, extraction and separation by temperature change, or extraction and separation using an adsorbent or absorbent may be performed.
[0024] (D) The pine bark extract may be in liquid form, or may be in paste or dry powder form. When it is in paste or dry powder form, it may be produced by itself or may be processed together with an excipient. The pine bark extract obtained by extraction may be purified by ultrafiltration, a column method using an adsorptive carrier (Diaion HP-20, Sephadex-LH20, chitin, etc.), a batch method, or the like.
[0025] The pine bark extract to be added to the skin external preparation is preferably in powder form, more preferably in dry powder form, from the viewpoint of storage stability and processability. The drying method is not particularly limited, and examples of the drying method include heating, sun drying, hot air drying, freeze drying, and reduced pressure drying of the pine bark extract containing a solvent. The solid pine bark extract may also be pulverized.
[0026] The pine bark extract may be commercially available, and examples of commercially available pine bark extract include Flavangenol (registered trademark; Toyo Shinyaku Co., Ltd.).
[0027] The pine bark extract (D) is encapsulated in liposomes containing hydrogenated soybean phospholipids (F). This improves the stability of the pine bark extract (D) in the topical skin preparation of the present invention, and enhances the moisturizing effect of the topical skin preparation, as well as the effect of improving the smoothness upon application and the firmness of the skin after use. The presence of the component (D) in the liposomes can be confirmed by, for example, liquid chromatography to confirm the presence of polyphenols derived from the component (D) after removing the liposomes.
[0028] In the skin topical preparation of the present invention, the amount of (D) pine bark extract is preferably 0.000001% by mass or more in the skin topical preparation, in order to enhance the effects of the present invention by using (D) pine bark extract. From this viewpoint, the amount of (D) pine bark extract in the skin topical preparation is even more preferably 0.000005% by mass or more, and particularly preferably 0.00001% by mass or more. From the same viewpoint, the amount of (D) pine bark extract in the skin topical preparation is preferably 10% by mass or less, even more preferably 5% by mass or less, and particularly preferably 1% by mass or less.
[0029] In the skin external preparation of the present invention, the amount of (D) pine bark extract is preferably 0.0001 to 10 parts by mass relative to 100 parts by mass of (A) niacinamide, in order to further improve the effects of the present invention. From this viewpoint, the amount of (D) pine bark extract is more preferably 0.0005 parts by mass or more, and particularly preferably 0.001 parts by mass or more, relative to 100 parts by mass of (A) niacinamide. In order to further improve the effects of the present invention, the amount of (D) pine bark extract is more preferably 8 parts by mass or less, and particularly preferably 5 parts by mass or less, relative to 100 parts by mass of (A) niacinamide. The amount of each of the above components (D) may be determined as the amount of solids.
[0030] (E) at least one selected from glutathione and ceramides The topical skin preparation of the present invention contains (E) at least one selected from glutathione and ceramides, which not only effectively enhances the moisturizing effect but also enhances the smoothness upon application and the firmness of the skin after use.
[0031] The glutathione may be reduced glutathione, oxidized glutathione, or a mixture thereof, but reduced glutathione is preferred because it is expected to exert an antioxidant effect.
[0032] Among ceramides, examples of ceramides that can be used include human ceramides such as ceramide 1, ceramide 2, and ceramide 3, as well as animal-derived ceramides extracted from the brain, spinal cord, etc. of cows, horses, pigs, etc., and plant-derived ceramides extracted from wheat, rice, soybeans, spinach, corn, konjac, pineapple, etc. The ceramide used in the present invention may be a glycoceramide, and specific examples include those bound to monosaccharides such as galactosylceramide and glucosylceramide, and those bound to oligosaccharides.
[0033] In the topical skin preparation of the present invention, it is preferable to use human ceramide, and examples thereof include N-stearoylphytosphingosine ("ceramide NP" or "ceramide 3"), N-oleoylphytosphingosine ("ceramide NP" or "ceramide 3"), N-stearoyldihydrosphingosine ("ceramide NG" or "ceramide 2"), stearoyloxyheptacosanoylphytosphingosine ("ceramide EOP" or "ceramide 1"), hydroxysphingosine ("ceramide EOP" or "ceramide 2"). At least one selected from cystearyl phytosphingosine ("ceramide AP" or "ceramide 6") is preferred, and in particular, at least one selected from N-stearoyl phytosphingosine ("ceramide NP" or "ceramide 3"), N-stearoyl dihydrosphingosine ("ceramide NG" or "ceramide 2") and hydroxystearyl phytosphingosine ("ceramide AP" or "ceramide 6") is preferably used.
[0034] At least one of glutathione (E) and ceramides is encapsulated in liposomes containing hydrogenated soybean phospholipid (F). This improves the stability of glutathione (E) and ceramides in the skin topical preparation of the present invention, thereby enhancing the moisturizing effect, as well as the effect of improving the smoothness upon application and the firmness of the skin after use. The presence of component (E) in the liposomes can be confirmed by, for example, IR (infrared spectroscopy) after removing the liposomes from the skin topical preparation.
[0035] In the skin external preparation of the present invention, when glutathione is contained, its amount is preferably 0.000001% by mass or more in the skin external preparation, in order to make the effect of the present invention by using glutathione excellent.From this viewpoint, the amount of glutathione in the skin external preparation is more preferably 0.000005% by mass or more, and particularly preferably 0.00001% by mass or more.Also, from the same viewpoint, the amount of glutathione in the skin external preparation is preferably 10% by mass or less, more preferably 5% by mass or less, and particularly preferably 1% by mass or less.
[0036] In the skin external preparation of the present invention, when glutathione is contained, the amount is preferably 0.01 to 50 parts by mass relative to 100 parts by mass of (A) niacinamide, in order to further improve the effects of the present invention. From this viewpoint, the amount of glutathione is more preferably 0.05 parts by mass or more relative to 100 parts by mass of (A) niacinamide, and particularly preferably 0.1 parts by mass or more. From the viewpoint of further improving the effects of the present invention, the amount of (C) glutathione is more preferably 30 parts by mass or less relative to 100 parts by mass of (A) niacinamide, and particularly preferably 10 parts by mass or less.
[0037] When the skin external preparation of the present invention contains ceramides, the amount of ceramides is preferably 0.000001% by mass or more in the skin external preparation, in order to make the effect of the present invention by using ceramides excellent.From this viewpoint, the amount of ceramides is more preferably 0.000005% by mass or more in the skin external preparation, and particularly preferably 0.00001% by mass or more.Also, from the same viewpoint, the amount of ceramides in the skin external preparation is preferably 0.01% by mass or less, more preferably 0.005% by mass or less, and particularly preferably 0.001% by mass or less.
[0038] In the skin external preparation of the present invention, when ceramides are contained, the amount is preferably 0.00001 to 1 part by mass relative to 100 parts by mass of (A) niacinamide, in order to further improve the effects of the present invention. From this viewpoint, the amount of ceramides is more preferably 0.00005 parts by mass or more relative to 100 parts by mass of (A) niacinamide, and particularly preferably 0.0001 parts by mass or more. From the viewpoint of further improving the effects of the present invention, the amount of ceramides is more preferably 0.1 parts by mass or less relative to 100 parts by mass of (A) niacinamide, and particularly preferably 0.01 parts by mass or less.
[0039] In the present invention, it is most preferable to use both (E) glutathione and ceramides in order to further enhance the moisturizing effect.
[0040] (F) Hydrogenated soybean phospholipids In the present invention, the skin external preparation contains liposomes containing (F) hydrogenated soybean phospholipid as a membrane component, and the liposomes contain at least one selected from (C) 3-O-ethyl ascorbic acid, (D) pine bark extract, and (E) glutathione and ceramides. This effectively enhances the moisturizing effect of the skin external preparation, and also enhances the effect of improving the smoothness of the skin upon application and the firmness of the skin after use. The reason for this is believed to be that the useful ingredients such as (C) 3-O-ethyl ascorbic acid, (D) pine bark extract, and (E) glutathione or ceramides are encapsulated in the liposomes, thereby increasing the permeability of the useful ingredients into the skin.
[0041] (F) Liposomes using hydrogenated soybean phospholipids are particularly important for maintaining the emulsification stability of topical skin preparations. As the hydrogenated soybean phospholipids used in the present invention, hydrogenated soybean lecithin or the like, in which unsaturated carbon chains in soybean phospholipids such as soybean lecithin are converted to saturated bonds by hydrogenation, can be used.
[0042] Liposomes containing (F) hydrogenated soybean phospholipid as a membrane component preferably have an average particle diameter of 30 nm to 300 nm, since this improves stability over time, improves the encapsulation rate of (C) to (E), and improves the permeability of the liposomes into the skin, etc. From these points of view, the average particle diameter of the liposomes is preferably 40 nm to 250 nm, and more preferably 50 nm to 200 nm. The average particle diameter of the liposomes can be measured by a commercially available particle size distribution meter such as a laser diffraction particle size distribution meter or a light scattering photometer, but is preferably measured by a dynamic light scattering particle size distribution measuring device. As the dynamic light scattering particle size distribution measuring device, a Zetasizer S manufactured by Malvern Instruments can be used.
[0043] In the present invention, liposomes encapsulating (C) to (E) can be prepared as follows. First, (F) hydrogenated soybean phospholipid is mixed with an organic solvent to prepare a phospholipid liquid. As the organic solvent, a dihydric alcohol can be preferably used. In order to successfully obtain liposomes encapsulating (C) to (E), the preparation of the phospholipid liquid is preferably carried out at 80 to 90°C, more preferably at 85 to 90°C.
[0044] In order to successfully obtain liposomes encapsulating (C) to (E), the amount of organic solvent for preparing the phospholipid liquid is preferably 180 to 400 parts by mass, more preferably 200 to 350 parts by mass, per 100 parts by mass of hydrogenated soybean phospholipid (F). In order to successfully obtain liposomes with an excellent encapsulation rate of the components (C) to (E), it is desirable to have the phospholipid liquid before adding the aqueous phase described below contain an oily component such as sterol. In addition, in order to successfully obtain liposomes encapsulating (C) to (E), the amount of hydrogenated soybean phospholipid (F) may be the ratio of (C) to (E) and (F) in the skin external preparation described below, per 100 parts by mass of the total amount of (C) to (E), but among them, 80 to 250 parts by mass is particularly preferable, and 100 to 220 parts by mass is even more preferable.
[0045] Next, an aqueous phase containing (C), (D) and (E) is prepared. The amount of water for preparing the aqueous phase may be appropriately adjusted to an appropriate amount in order to disperse (C), (D) and (E) and encapsulate the phospholipid described below, but may be 1,000 to 5,000,000 parts by mass, or 4,000 to 2,000,000 parts by mass relative to 100 parts by mass of the total amount of (C), (D) and (E). In order to successfully obtain liposomes with excellent encapsulation rates of the (C) to (E) components, the preparation of the aqueous phase containing (C), (D) and (E) is preferably performed at 80 to 90 ° C, more preferably at 85 to 90 ° C. The timing of adding (C), (D) and (E) to water may be once or at different times.
[0046] Next, the phospholipid liquid and the aqueous phase are mixed. In order to successfully obtain liposomes with excellent encapsulation rates of the components (C) to (E), this mixing is preferably carried out at 80 to 90° C., and more preferably at 85 to 90° C. This mixing can also be carried out by gentle stirring using a propeller or the like.
[0047] In the above-mentioned production method, the component (A) is preferably added to the external skin preparation at a timing after the preparation of the liposomes. In addition, it is preferable to add component (B) to the topical skin preparation at a timing after the preparation of liposomes.
[0048] The content of (F) hydrogenated soybean phospholipid in the skin topical preparation is preferably 0.001% by mass or more from the viewpoint of successfully obtaining liposomes with excellent encapsulation rates of the (C) to (E) components, more preferably 0.01% by mass or more, and particularly preferably 0.05% by mass or more. The content of (F) hydrogenated soybean phospholipid in the skin topical preparation is preferably 20% by mass or less from the viewpoint of obtaining a skin topical preparation that is smooth to the touch and has excellent skin permeability, more preferably 10% by mass or less, and even more preferably 5% by mass or less.
[0049] The content of hydrogenated soybean phospholipid (F) in the skin topical preparation is preferably 0.01 parts by mass or more per part by mass of the total amount of (C), (D) and (E) in order to successfully obtain a liposome membrane with an excellent encapsulation rate of the (C) to (E) components, more preferably 0.05 parts by mass or more, and particularly preferably 0.1 parts by mass or more. The content of hydrogenated soybean phospholipid (F) in the skin topical preparation is preferably 20 parts by mass or less per part by mass of the total amount of (C), (D) and (E) in order to obtain a skin topical preparation that is smooth to use and has excellent skin penetration, more preferably 15 parts by mass or less, and even more preferably 10 parts by mass or less.
[0050] The skin topical preparation of the present invention preferably further contains at least one component selected from (G1) antioxidants, (G2) moisturizing agents, (G3) anti-inflammatory agents, (G4) whitening agents, (G5) vitamins, and (G6) peeling agents as a component other than the components (A) to (F), in order to enhance the moisturizing effect and effectively improve the smoothness upon application and the transparency and firmness of the skin after use. Note that a peeling agent refers to an agent used for increasing the flexibility of keratin and removing it.
[0051] (G1) Antioxidants include ubiquinone and astaxanthin, and astaxanthin is particularly preferred from the viewpoint of improving moisturizing effect and usability. Astaxanthin is known to be contained in Haematococcus algae, crustaceans such as shrimp and crab, salmon, etc. Astaxanthin that can be used in the present invention is not particularly limited, but astaxanthin derived from Haematococcus algae is preferred from the viewpoint of easy use. Haematococcus (Haematococcus pluvialis) is a type of microalgae.
[0052] In the skin external preparation of the present invention, when the skin external preparation contains the antioxidant (G1), the amount of the antioxidant is preferably 0.000001% by mass or more in order to make the effect of the present invention by using the antioxidant (G1) excellent. From this viewpoint, the amount of the antioxidant (G1) in the skin external preparation is more preferably 0.000005% by mass or more, and particularly preferably 0.00001% by mass or more. From the same viewpoint, the amount of the antioxidant (G1) in the skin external preparation is preferably 1% by mass or less, more preferably 0.5% by mass or less, and particularly preferably 0.1% by mass or less.
[0053] In the skin external preparation of the present invention, when the antioxidant (G1) is contained, the amount of the antioxidant (G1) is preferably 0.00005 to 0.2 parts by mass relative to 100 parts by mass of niacinamide (A) in order to improve the moisturizing effect and the improvement effect of the feeling of use using the antioxidant (G1). From this viewpoint, the amount of the antioxidant (G1) is more preferably 0.0002 parts by mass or more relative to 100 parts by mass of niacinamide (A), and particularly preferably 0.0005 parts by mass or more. In order to further improve the effect of the present invention, the amount of the antioxidant (G1) is more preferably 0.08 parts by mass or less relative to 100 parts by mass of niacinamide (A), and particularly preferably 0.05 parts by mass or less.
[0054] The antioxidant (G1) may be encapsulated in a liposome containing the hydrogenated soybean phospholipid (F) as a membrane component, or may be present in the external aqueous phase outside the liposome, but is preferably present in the external aqueous phase.
[0055] (G2) Moisturizing agents include bilberry leaf extract; Phellodendron bark extract; hydrolyzed hyaluronic acid, acetylated hyaluronic acid, sodium hyaluronate; 2-methacryloyloxyethyl phosphorylcholine-butyl methacrylate copolymer; heparinoids; isomerized sugar; proteoglycan; and aminobutyric acid. Among them, bilberry leaf extract is particularly preferred from the viewpoint of improving moisturizing effect and feeling of use. "Bilberry" (also known as Vaccinium myrtillus L.) may be used as the leaf of a plant of the Ericaceae family and the Vaccinium genus, but the leaf of the same genus plant, Vaccinium smallii A. Gray var glabrum Koidz., may also be used. In addition, the part to be extracted may contain other parts such as stems and flowers as long as it contains leaves.
[0056] The bilberry leaf extract may be an extract containing the leaves of a plant body, either directly or after crushing, and squeezed out, or may be an extract extracted with a solvent, either directly or after crushing. As the extraction solvent, water, a hydrophilic organic solvent, or a water-containing hydrophilic organic solvent may be used. As the hydrophilic organic solvent, lower aliphatic alcohols having 1 to 3 carbon atoms, such as methanol, ethanol, propanol, and isopropanol, and polyhydric alcohols having 2 to 4 carbon atoms, such as 1,3-butylene glycol, propylene glycol, and glycerin, may be used.
[0057] In the skin external preparation of the present invention, when the skin external preparation contains the moisturizing agent (G2), the amount of the moisturizing agent is preferably 0.000001% by mass or more in order to obtain excellent antioxidant effects and the like due to the use of the moisturizing agent (G2). From this viewpoint, the amount of the moisturizing agent (G2) in the skin external preparation is more preferably 0.000005% by mass or more, and particularly preferably 0.00001% by mass or more. From the same viewpoint, the amount of the moisturizing agent (G2) in the skin external preparation is preferably 1% by mass or less, more preferably 0.5% by mass or less, and particularly preferably 0.1% by mass or less.
[0058] In the skin external preparation of the present invention, when the moisturizing agent (G2) is contained, the amount of the moisturizing agent (G2) is preferably 0.0001 to 0.2 parts by mass relative to 100 parts by mass of niacinamide (A), in order to further improve the effects of the present invention. From this viewpoint, the amount of the moisturizing agent (G2) is more preferably 0.0005 parts by mass or more relative to 100 parts by mass of niacinamide (A), and particularly preferably 0.001 parts by mass or more. From the viewpoint of further improving the effects of the present invention, the amount of the moisturizing agent (G2) is more preferably 0.1 parts by mass or less relative to 100 parts by mass of niacinamide (A), and particularly preferably 0.02 parts by mass or less. Each amount of the above (G2) can be the amount of solid content.
[0059] The moisturizing agent (G2) may be encapsulated in a liposome containing the hydrogenated soybean phospholipid (F) as a membrane component, or may be present in the external aqueous phase outside the liposome, but is preferably present in the external aqueous phase.
[0060] (G3) anti-inflammatory agents include dipotassium glycyrrhizinate, stearyl glycyrrhetinate, Centella asiatica leaf extract, and allantoin, and Centella asiatica leaf extract is particularly preferred from the viewpoint of improving moisturizing effect and usability. Centella asiatica leaf extract is an extract of Centella asiatica leaves. Centella asiatica leaf extract may be one that uses other parts such as flowers and stems in addition to Centella asiatica leaves. Centella asiatica leaf extract can be one that uses Centella asiatica leaves as they are, or dried leaves, crushed leaves, or crushed leaves squeezed and extracted with an extraction solvent. As the extraction solvent, water (including hot water), methanol, ethanol, isopropanol, ethylene glycol, propylene glycol, butylene glycol, alcohols such as glycerin, esters such as ethyl acetate, ketones such as acetone and methyl ethyl ketone, nitriles such as acetonitrile, ethers such as diethyl ether and tetrahydrofuran, saturated hydrocarbons such as pentane, hexane, cyclopentane, and cyclohexane, aromatic hydrocarbons such as toluene, halogenated hydrocarbons such as dichloromethane and chloroform, and other organic solvents such as dimethylformamide and dimethyl sulfoxide (which may all contain water), may be used appropriately, and may be any mixture of one or two of them. As the extraction solvent, alcohols are preferable, and ethanol, propylene glycol, and butylene glycol are more preferable.
[0061] In the skin external preparation of the present invention, when the anti-inflammatory agent (G3) is contained, the amount of the anti-inflammatory agent is preferably 0.000001% by mass or more in the skin external preparation, in order to make the effect of antioxidation and the like by using the anti-inflammatory agent (G3) excellent. From this viewpoint, the amount of the anti-inflammatory agent (G3) in the skin external preparation is more preferably 0.000005% by mass or more, and particularly preferably 0.00001% by mass or more. From the same viewpoint, the amount of the anti-inflammatory agent (G3) in the skin external preparation is preferably 1% by mass or less, more preferably 0.5% by mass or less, and particularly preferably 0.3% by mass or less.
[0062] In the skin external preparation of the present invention, when the anti-inflammatory agent (G3) is contained, the amount is preferably 0.1 to 25 parts by mass relative to 100 parts by mass of niacinamide (A) in order to improve the moisturizing effect and the effect of improving the feeling of use. From this viewpoint, the amount of the anti-inflammatory agent (G3) is more preferably 0.2 parts by mass or more relative to 100 parts by mass of niacinamide (A), and particularly preferably 0.5 parts by mass or more. From the viewpoint of further improving the effect of the present invention, the amount of the anti-inflammatory agent (G3) is more preferably 20 parts by mass or less relative to 100 parts by mass of niacinamide (A), and particularly preferably 10 parts by mass or less. The amount of each of the above components (G3) may be the amount of solid content.
[0063] The (G3) anti-inflammatory agent may be encapsulated in a liposome containing (F) hydrogenated soybean phospholipid as a membrane component, or may be present in the external aqueous phase outside the liposome, but is preferably present in the external aqueous phase.
[0064] (G4) Skin whitening agents include ascorbic acid, 3-laurylglyceryl ascorbic acid, myristyl 3-glyceryl ascorbic acid, bisglyceryl ascorbic acid, 3-glyceryl ascorbic acid, ascorbyl palmitate phosphate trisodium, ascorbyl tetrahexyldecanoate, L-ascorbic acid 2-glucoside, ascorbyl magnesium phosphate, ascorbyl sodium phosphate, etc. ascorbic acid derivatives; tranexamic acid, hydroquinone, arbutin, placenta extract, kojic acid, etc. Among these, ascorbic acid derivatives are preferred, and bisglyceryl ascorbic acid is particularly preferred from the viewpoint of enhancing the moisturizing effect and the feeling of use.
[0065] When the skin external preparation of the present invention contains a (G4) whitening agent, the amount of the whitening agent is preferably 0.000001% by mass or more in terms of solid content in the skin external preparation, in order to obtain excellent effects such as improved transparency by using the (G4) whitening agent. From this viewpoint, the amount of Centella asiatica leaf extract in the skin external preparation is more preferably 0.000005% by mass or more, and particularly preferably 0.00001% by mass or more. From the same viewpoint, the amount of the (G4) whitening agent in the skin external preparation is preferably 1% by mass or less, more preferably 0.5% by mass or less, and particularly preferably 0.1% by mass or less.
[0066] In the skin external preparation of the present invention, when the skin whitening agent (G4) is contained, the amount of the skin whitening agent (G4) is preferably 0.1 to 25 parts by mass as solid content relative to 100 parts by mass of niacinamide (A) in order to improve the moisturizing effect and the effect of improving the feeling of use. From this viewpoint, the amount of the skin whitening agent (G4) is more preferably 0.2 parts by mass or more relative to 100 parts by mass of niacinamide (A), and particularly preferably 0.5 parts by mass or more. In order to further improve the effects of the present invention, the amount of the skin whitening agent (G4) is more preferably 20 parts by mass or less relative to 100 parts by mass of niacinamide (A), and particularly preferably 10 parts by mass or less.
[0067] The (G4) skin whitening agent may be encapsulated in a liposome containing (F) hydrogenated soybean phospholipid as a membrane component, or may be present in the external aqueous phase outside the liposome, but is preferably present in the external aqueous phase.
[0068] (G5) Vitamins include salts and derivatives of vitamins A, B, E, and P, such as biotin, calcium pantothenate, tocopherol, tocopherol acetate, sodium tocopheryl phosphate, retinol, retinol palmitate, retinol acetate, retinol propionate, retinol linoleate, hydrogenated retinol, cyanocobalamin, folic acid, glucosyl hesperindin, and pyridoxine hydrochloride. Among them, tocopherol is preferred in terms of moisturizing effect and usability. Tocopherol may be any of α, β, γ, and δ.
[0069] In the skin external preparation of the present invention, when the skin external preparation contains (G5) vitamins, the amount of the vitamins is preferably 0.000001 mass% or more as solid content in the skin external preparation, in order to enhance the antioxidant effect and the like by using (G5) vitamins. From this viewpoint, the amount of (G5) vitamins in the skin external preparation is more preferably 0.000005 mass% or more, and particularly preferably 0.00001 mass% or more. From the same viewpoint, the amount of (G5) vitamins in the skin external preparation is preferably 1 mass% or less, more preferably 0.5 mass% or less, and particularly preferably 0.2 mass% or less.
[0070] In the skin external preparation of the present invention, when it contains (G5) vitamins, the amount of (G5) vitamins is preferably 0.1 to 25 parts by mass relative to 100 parts by mass of (A) niacinamide, in terms of improving moisturizing effect and usability. From this viewpoint, the amount of (G5) vitamins is more preferably 0.2 parts by mass or more relative to 100 parts by mass of (A) niacinamide, and particularly preferably 0.5 parts by mass or more. In terms of further improving the effects of the present invention, the amount of (G5) vitamins is more preferably 20 parts by mass or less relative to 100 parts by mass of (A) niacinamide, and particularly preferably 10 parts by mass or less.
[0071] The (G5) vitamins may be encapsulated in liposomes containing (F) hydrogenated soybean phospholipid as a membrane component, or may be present in the external aqueous phase outside the liposome, but are preferably present in the external aqueous phase.
[0072] As the peeling agent (G6), organic acids are suitable, such as lactic acid, salicylic acid, glycolic acid, malic acid, mandelic acid, and lactobionic acid. Of these, lactic acid is particularly preferred in terms of its moisturizing effect and usability.
[0073] In the skin external preparation of the present invention, when the peeling agent (G6) is contained, the amount of the peeling agent is preferably 0.000001% by mass or more in the skin external preparation, in order to improve the peeling effect by using the peeling agent. From this viewpoint, the amount of the peeling agent (G6) in the skin external preparation is more preferably 0.000005% by mass or more, and particularly preferably 0.00001% by mass or more. From the same viewpoint, the amount of the peeling agent (G6) in the skin external preparation is preferably 1% by mass or less, more preferably 0.5% by mass or less, and particularly preferably 0.2% by mass or less.
[0074] In the skin external preparation of the present invention, when the peeling agent (G6) is contained, the amount of the peeling agent (G6) is preferably 0.1 to 25 parts by mass relative to 100 parts by mass of niacinamide (A) in order to improve the moisturizing effect and the improvement effect of the feeling of use. From this viewpoint, the amount of the peeling agent (G6) is more preferably 0.2 parts by mass or more relative to 100 parts by mass of niacinamide (A), and particularly preferably 0.5 parts by mass or more. From the viewpoint of further improving the effect of the present invention, the amount of the peeling agent (G6) is more preferably 20 parts by mass or less relative to 100 parts by mass of niacinamide (A), and particularly preferably 10 parts by mass or less.
[0075] The peeling agent (G6) may be encapsulated in a liposome containing (F) hydrogenated soybean phospholipid as a membrane component, or may be present in the external aqueous phase outside the liposome, but is preferably present in the external aqueous phase.
[0076] The at least one selected from (G) antioxidants, (G2) moisturizing agents, (G3) anti-inflammatory agents, (G4) whitening agents, (G5) vitamins, and (G6) peeling agents is preferably one or more selected from (g1) astaxanthin, (g2) bilberry leaf extract, (g3) Centella asiatica leaf extract, (g4) bisglyceryl ascorbic acid, (g5) tocopherol, and (g6) lactic acid, and in particular, the inclusion of bilberry leaf extract is preferred in terms of increasing the moisture content of the stratum corneum. It is also preferable for the composition to contain all of (G1) an antioxidant, (G2) a moisturizing agent, (G3) an anti-inflammatory agent, (G4) a skin-whitening agent, (G5) vitamins, and (G6) a peeling agent. In particular, it is preferable for the composition to contain all of (g1) astaxanthin, (g2) bilberry leaf extract, (g3) Centella asiatica leaf extract, (g4) bisglyceryl ascorbic acid, (g5) tocopherol, and (g6) lactic acid, in that it not only significantly enhances the moisturizing effect, but also provides excellent and remarkable smoothness upon application and transparency and firmness of the skin after use.
[0077] In addition to the above-mentioned components, the skin topical preparation may contain (H) other components, such as organic solvents, sterols, oils other than sterols, thickeners, chelating agents, pH adjusters, fragrances, surfactants, and preservatives, which are generally used in skin topical preparations. The organic solvent may be any of the organic solvents used to prepare the phospholipid solution listed above, or in addition to the organic solvents, monohydric alcohols having 4 or less carbon atoms, such as ethanol, 2-propanol (isopropyl alcohol), butanol, and isobutyl alcohol; dihydric alcohols having 5 to 12 carbon atoms, such as propylene glycol, 1,3-butylene glycol, pentylene glycol, isopentyl diol, diethylene glycol, dipropylene glycol, ethylhexylglycerin, 1,3-propanediol, 1,5-pentanediol, 1,2-hexanediol, 1,2-octanediol, and 1,2-decanediol; diethylene glycol monoethyl ether; Examples of the glycol ethers include glycol ethers such as ethylene glycol monoethyl ether (ethoxydiglycol), ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, triethylene glycol monoethyl ether, diethylene glycol diethyl ether, diethylene glycol dibutyl ether, propylene glycol monoethyl ether, and dipropylene glycol monoethyl ether; glycol ether esters such as ethylene glycol monoethyl ether acetate, diethylene glycol monoethyl ether acetate, and propylene glycol monoethyl ether acetate; and glycol esters such as diethoxyethyl succinate and ethylene glycol disuccinate. Among these, it is preferable to use a dihydric alcohol having 5 to 12 carbon atoms in terms of moisturizing properties, feeling in use, and bacteriostasis, and it is particularly preferable to use 1,3-butylene glycol and / or pentylene glycol.
[0078] From the viewpoints of smoothness, moisturizing property, and bacteriostasis during use, the amount of the organic solvent in the skin external preparation is preferably 1 to 35% by mass, more preferably 3 to 25% by mass. When 1,3-butylene glycol and / or pentylene glycol is used, the amount of pentylene glycol is preferably 10 to 50 parts by mass per 100 parts by mass of 1,3-butylene glycol.
[0079] Examples of sterols include those contained as a component of the membrane containing (F) hydrogenated soybean phospholipid. For example, liposomes may contain sterols as a membrane component in addition to (F) hydrogenated soybean phospholipid. According to an external skin preparation having such a configuration, the liposome membrane is stabilized, and thus the moisturizing effect, smoothness at the time of application, transparency after use, and firmness effect due to the combination of (C), (D), and (E) described above are more easily improved. Examples of sterols include cholesterol and phytosterol, and phytosterol is preferred in terms of the feeling of use and the stability of liposomes. Phytosterol is a general term for sterols contained in plants, and β-sitosterol, stigmasterol, campesterol, brassicasterol, etc. are known as main components. The sterol may be a mixture of multiple sterols.
[0080] When sterol is contained, the content of sterol in the skin external preparation is preferably 0.01% by mass or more from the viewpoint of more successfully obtaining a liposome membrane with an excellent encapsulation rate of the (C) to (E) components, more preferably 0.04% by mass or more, and particularly preferably 0.08% by mass or more. When sterol is contained, the content of sterol in the skin external preparation is preferably 10% by mass or less from the viewpoint of easily obtaining a skin external preparation with a smooth feel and excellent skin permeability and from the viewpoint of good stability of the liposome, more preferably 5% by mass or less, and even more preferably 3% by mass or less. When sterol is added in the above-mentioned liposome production process, it is preferable from the viewpoint of usability and liposome stability to add the sterol to the phospholipid liquid for preparing the liposomes or to add the sterol at the timing of mixing the hydrogenated soybean phospholipid and the encapsulated component.
[0081] Oils include vegetable oils such as safflower oil, soybean oil, evening primrose oil, grape seed oil, rosehip oil, kukui nut oil, almond oil, sesame oil, wheat germ oil, corn oil, cottonseed oil, avocado oil, olive oil, camellia oil, persic oil, castor oil, peanut oil, hazelnut oil, macadamia nut oil, and medfoam oil; animal oils such as squalane; hydrocarbon oils such as liquid paraffin, liquid isoparaffin, and petrolatum; ethyl oleate, ethyl linoleate, and myristic acid. isopropyl acetate, isopropyl palmitate, isopropyl isostearate, isopropyl lanolate, hexyl laurate, myristyl myristate, cetyl myristate, octyldodecyl myristate, decyl oleate, octyldodecyl oleate, hexyldecyl dimethyloctanoate, cetyl octanoate, isocetyl octanoate, cetostearyl octanoate, stearyl octanoate, isostearyl octanoate, cetyl palmitate, cetyl lactate, Examples of the oils that can be used include ester oils such as diisostearyl malate, dioctyl succinate, glyceryl tricaprylate, glyceryl tri-2-ethylhexanoate (triethylhexanoin), glyceryl trilaurate, glyceryl tripalmitate, glyceryl tristearate, glyceryl trioxystearate, glyceryl triisostearate, glyceryl trioleate, glyceryl triundecylenate, glyceryl tribehenate, glycerin trimyristate, tri(caprylic / capric acid)glycerin, propylene glycol dicaprylate, propylene glycol dicaprate, propylene glycol dinonanoate, propylene glycol di(caprylic / capric acid), propylene glycol distearate, propylene glycol diisodistearate, and propylene glycol dioleate; and silicone oils such as cyclic silicone, methylphenyl silicone, and dimethicone. One or more of these oils can be selected and used. In particular, it is preferable to use ester oil and / or silicone oil. As the ester oil, glyceryl tri-2-ethylhexanoate is preferred, and as the silicone oil, dimethicone is preferred.
[0082] When the oil is contained, the content of the oil in the skin external preparation is preferably 0.5% by mass to 30% by mass in terms of the feeling of use, and more preferably 1% by mass to 20% by mass. When the ester oil and the silicone oil are combined, the preferred mass ratio of the two is 100 parts by mass of the ester oil and 0.1 to 60 parts by mass of the silicone oil.
[0083] Examples of thickeners include various types of thickeners that can be used in the fields of cosmetics and pharmaceuticals, such as natural polysaccharides, cellulose-based polymers, synthetic polymers, and clay minerals.
[0084] Examples of natural polysaccharides include polysaccharides derived from animals and plants or from microbial fermentation, and specifically include xanthan gum, succinoglycan, carrageenan, guar gum, locust bean gum, galactan, gum arabic, tragacanth gum, tamarind gum, agar, agarose, mannan, curdlan, alginic acid or its salts, gum arabic, pectin, quince seed, starch, algae colloid, chondroitin sulfate or its salts, chitosan and its derivatives, nucleic acid or its salts, ribonucleic acid or its salts, casein, collagen, gelatin, albumin, fibroin, elastin, keratin, sericin and other water-soluble proteins, hyaluronic acid or its salts, chondroitin sulfate and other mucopolysaccharides. Among these, xanthan gum is preferred from the viewpoint of usability.
[0085] The cellulose-based polymer is a polymer composed of units of cellulose or its derivatives. Specific examples include carboxymethylcellulose or its salts, methylcellulose, ethylcellulose, propylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose, and sulfonated cellulose derivatives.
[0086] A synthetic polymer is a polymer artificially synthesized using monomers as structural units. Specific examples include vinyl polymers such as carboxyvinyl polymers and polyvinyl alcohol, acrylic acid-alkyl methacrylate copolymers, acrylates / alkyl acrylate crosspolymers, acrylic acid polymers such as polyacrylic acid, acrylamide polymers such as polyalkylacrylamide / polyacrylamide copolymers, and (PEG-240 / decyltetradeceth-20 / HDI) copolymers. Among these, carboxyvinyl polymers and acrylic acid-alkyl methacrylate copolymers are preferred from the viewpoint of usability.
[0087] Clay minerals refer to substances commonly known as the main component minerals that make up clay, such as laponite, bentonite, smectite kaolinite, and montmorillonite.
[0088] In the present invention, it is preferable to use natural polysaccharides and / or synthetic polymers.
[0089] The amount of thickener in the topical skin preparation is preferably 0.1 to 3 mass %. When a natural polysaccharide and a synthetic polymer are combined, the mass ratio of the two is preferably 100 parts by mass of natural polysaccharide to 50 to 350 parts by mass of synthetic polymer.
[0090] Antibacterial and preservative agents include parabens (hydroxybenzoic acid esters) such as methylparaben, ethylparaben, propylparaben, and butylparaben; phenoxyethanol; alkyl glyceryl ethers such as 2-ethylhexylglyceryl ether (ethylhexylglycerin); salicylic acid; lanolin fatty acids and their salts; sodium benzoate; isothiazolinone derivatives such as methylchloroisothiazolinone and methylisothiazolinone; imidazolinium urea; dehydroacetic acid and its salts; phenols; and haloisothiazolinone such as triclosan. Examples of the 1,2-alkanediols include 1,2-alkanediols such as 1,2-alkanediols, ...
[0091] The amount of the antibacterial / antiseptic agent in the external skin preparation is preferably 0.01 to 1% by mass, and more preferably 0.05 to 0.5% by mass.
[0092] Examples of chelating agents include edetates (ethylenediaminetetraacetates) such as EDTA, EDTA2Na, EDTA3Na, and EDTA4Na; hydroxyethylethylenediaminetriacetates such as HEDTA3Na; pentetates (diethylenetriaminepentaacetate); phytic acid; phosphonic acids such as etidronic acid and salts thereof such as their sodium salts; sodium oxalate; polyamino acids such as polyaspartic acid and polyglutamic acid; sodium polyphosphate, sodium metaphosphate, phosphoric acid; sodium citrate, and citric acid.
[0093] The amount of the chelating agent in the external skin preparation is preferably 0.008 to 1% by mass, and more preferably 0.01 to 0.5% by mass.
[0094] Preferred examples of the pH adjuster, acid, or alkali include acetic acid, sodium acetate, hydrochloric acid, sulfuric acid, monoethanolamine, diethanolamine, triethanolamine, isopropanolamine, triisopropanolamine, 2-amino-2-methyl-1,3-propanediol, 2-amino-2-hydroxymethyl-1,3-propanediol, arginine, sodium hydroxide, potassium hydroxide, aqueous ammonia, guanidine carbonate, and ammonium carbonate.
[0095] Although not limited thereto, the amount of water is preferably 40 to 90% by mass in the external skin preparation.
[0096] The types of the external skin preparation of the present invention include hair cosmetics, skin cosmetics, make-up cosmetics, fragrance cosmetics, body cosmetics, etc. The external skin preparation of the present invention can be produced according to a conventional method.
[0097] To explain the types of topical skin preparations of the present invention in more detail, preferred examples of hair cosmetics include shampoos such as oil shampoo, cream shampoo, conditioning shampoo, anti-dandruff shampoo, hair color shampoo, and rinse-integrated shampoo; hair care agents such as rinse, conditioner, treatment, hair pack, hair mist, and hair oil; hair styling products such as hair foam, hair mousse, hair spray, hair wax, hair gel, hair cream, water grease, setting lotion, pomade, and hair styling products; hair dyes such as color lotions, hair color treatments, hair manicures, and oxidation hair dyes; hair tonics, hair liquids, hair blow dryers, split end coats, permanent wave agents, straight perm agents, hair bleach, hair color pre-treatments, hair color after-treatments, perm pre-treatments, perm after-treatments, and hair growth agents.
[0098] Skin cosmetics include lotions such as softening lotion, astringent lotion, cleansing lotion, multi-layered lotion, and liposome lotion; emulsions such as emollient lotion, moisture lotion, milky lotion, nourishing lotion, nourishing milk, skin moisture, moisturizing emulsion, massage lotion, exfoliating smoother, elbow lotion, hand lotion, and body lotion; emollient cream, nourishing cream, nourishing cream, vanishing cream, moisture cream, night cream, massage cream, cleansing cream, makeup cream, base cream, pre-makeup cream, sunscreen cream, suntan cream, hair removal cream, deodorant cream, shaving cream, and other skin care products. Preferred examples of such products include creams such as moisturizing cream and exfoliating cream; gels such as moisturizing gel, whitening gel, and all-in-one gel; beauty serums such as moisturizing essence, whitening essence, moisturizing serum, and whitening serum; sunscreens such as sun protect, sun protector, UV care milk, and sunscreen; packs and masks such as peel-off packs, powder packs, washing packs, oil packs, and cleansing masks; makeup removers such as cleansing foam, cleansing cream, cleansing milk, cleansing lotion, cleansing gel, and cleansing oil; and facial cleansers such as paste facial cleanser, gel facial cleanser, foam facial cleanser, facial cleansing powder, cosmetic soap, transparent soap, medicated soap, liquid soap, and shaving soap.
[0099] Preferred examples of makeup cosmetics include lipstick, lip gloss, foundation, blush, face powder, concealer, eyeliner, mascara, eye shadow, eyebrow pencil, nail enamel, enamel remover, and nail treatment.
[0100] Preferred examples of the aromatic cosmetic include perfume, perfume, parfum, eau de parfum, eau de toilette, eau de cologne, perfume paste, aromatic powder, perfumed soap, body lotion, and bath oil.
[0101] Preferred examples of body cosmetics include body cleansers such as body shampoos, deodorant cosmetics such as deodorant lotions, deodorant powders, deodorant sprays and deodorant sticks, bleaches, depilatories, bath additives, and insect repellents such as insect repellent sprays.
[0102] Among these, the types of external skin preparations of the present invention are preferably lotions, milky lotions, creams, gels, beauty essences, packs, makeup removers, facial cleansers, etc., in terms of their moisturizing effect and improving the feeling of use.
[0103] Preferred examples of the formulation of the topical skin preparation of the present invention include emulsion-type cosmetics such as oil-in-water (O / W) type, water-in-oil (W / O) type, W / O / W type, and O / W / O type, oil-based cosmetics, solid cosmetics, liquid cosmetics, paste cosmetics, stick-type cosmetics, volatile oil-type cosmetics, powder cosmetics, jelly-type cosmetics, gel-type cosmetics, paste-type cosmetics, emulsified polymer-type cosmetics, sheet-type cosmetics, mist-type cosmetics, and spray-type cosmetics. When the topical skin preparation of the present invention is an emulsion, the continuous phase may be either an aqueous phase or an oil phase. In the examples described below, a composition in which the continuous phase is an aqueous phase is prepared. EXAMPLES
[0104] The present invention will be described below based on examples, but the present invention is not limited to the following examples. In each of the Examples and Comparative Examples 1 to 5, the average particle size of the liposomes was 100 to 150 nm.
[0105] <Test substance> (A) Niacinamide having a purity of 98% by mass or more was used. (B) D-pantothenyl alcohol having a purity of 98% by mass or more was used. (C) 3-O-ethyl ascorbic acid with a purity of 95% by mass was used. (D) As the pine bark extract, a hot water extract (dried powder) of French maritime pine bark was used.
[0106] (E1) Glutathione used was of reduced type with a purity of 98% by mass or more. (E2) N-stearoylphytosphingosine (ceramide NP) was used as the ceramide.
[0107] (F) Hydrogenated soybean phospholipid: Hydrogenated soybean lecithin (purity 100% by mass) was used. (g2) Bilberry leaf extract was prepared by extracting a powder using water and 1,3-butylene glycol as an extraction solvent in a mass ratio of 1:1. The purity was 0.2 mass%, with the remainder being water and 1,3-butylene glycol. (g1) Astaxanthin was derived from Haematococcus algae and had a purity of 50% by mass, with the remainder being tri(caprylic acid / capric acid)glyceryl. (g3) As the Centella asiatica leaf extract, a purified extract with a purity of 100% by mass was used. (g4) Bisglyceryl ascorbic acid with a purity of 50% by mass was used, with the remainder being water and glycerin. (g5) As the tocopherol, natural tocopherol with a purity of 100% by mass was used. (g6) Lactic acid with a purity of 90% by mass was used. The remainder was water.
[0108] (H1) Phytosterol: Phytosterol with a purity of 100% by mass was used. (H2)BG (1,3-butylene glycol) (H3) Pentylene glycol (H4) Triethylhexanoin (H5) Dimethicone (H6) Xanthan gum (H7) Carboxyvinyl polymer (H8) Potassium hydroxide (H9)EDTA-2Na (H10) Phenoxyethanol (H11) The fragrance used had a woody scent. (H12)Water
[0109] Example 1 The components used were (A)-(D), (E1), (E2), (F), and (H1)-(H12). (Step 1: Preparation of liposomes) Of the above components, (F), (H1), and (H3) were mixed at 85° C. (Liquid 1). The mixing was performed by adding (H1) and (H3) to (F) in that order. Among the above components, (C), (D), (E1), and (E2) were mixed with (H12) in an amount equivalent to 13% by mass of the total amount of the topical skin preparation at 85° C. (Liquid 2). Mixing was performed by adding (C) to (E) to (H12) in the following order: (C), (D), (E). Liquid 2 was added to Liquid 1 and mixed by stirring at 85° C. A liposome dispersion was obtained by the above process. (2nd process) The obtained liposome dispersion liquid and the other materials ((A), (B), (H2), (H4) to the remaining (H12)) that had been mixed and emulsified in advance were stirred and mixed at 45° C. As a result, a viscous liquid skin preparation for external use was obtained.
[0110] (Examples 2 and 3) An external skin preparation was obtained in the same manner as in Example 1, except that the amount of (A) niacinamide was changed and (E1) ceramide or (E2) glutathione was not used.
[0111] Example 4 (A) An external skin preparation was obtained in the same manner as in Example 1, except that the amount of niacinamide was changed.
[0112] Example 5 (g2) Bilberry leaf extract was added together with (A), (B), (H2), (H4) to (H12) in the second step. Except for this, a skin topical preparation was obtained in the same manner as in Example 4.
[0113] Example 6 (g1) Astaxanthin, (g3) Centella asiatica leaf extract, (g4) Bisglyceryl ascorbic acid, (g5) Tocopherol, and (g6) Lactic acid were added together with (A), (B), (H2), (H4) to (H12) in the second step. Except for this, a skin topical preparation was obtained in the same manner as in Example 5.
[0114] (Comparative Examples 1 to 5) As shown in Table 1, an external skin preparation was obtained in the same manner as in Example 4, except that (A), (B), (C), (D) or (E) was not used.
[0115] Comparative Example 6 (F) Hydrogenated soybean phospholipid and (H1) phytosterol were not used. Except for this, the procedure of Example 4 was repeated to obtain an external skin preparation.
[0116] [Evaluation 1: Moisture content of stratum corneum] Five professional monitors (healthy men and women in their 20s and 30s) were randomly selected as subjects. The inside of each subject's forearm was washed with a facial cleanser and allowed to rest for 15 minutes in a measurement room. Next, the above-mentioned skin preparation was applied to a 4 cm x 4 cm area on the inside of the forearm and left to stand for 10 minutes. The skin preparation was then removed and the subject was washed with water. The moisture content of the stratum corneum (μS) was measured after washing. The results are shown in Table 1. The moisture content of the stratum corneum was measured using a skin epidermal moisture content measuring device, SKICON-200EX (manufactured by IBS Co., Ltd.) This device evaluates the moisture content of the stratum corneum as the skin conductance (electrical conductivity, unit: μS). The higher the stratum corneum moisture content, the greater the moisturizing effect.
[0117] [Evaluation 2: Usability] Five professional monitors (healthy men and women in their 20s and 30s) were randomly selected as subjects. The inside of each subject's forearm was washed with a facial cleanser and they were allowed to rest for 15 minutes in the measurement room. Next, the above-mentioned skin preparation was applied to a 4 cm x 4 cm area on the inside of the forearm. Evaluation items (3 items) after use were evaluated based on the following evaluation criteria. The evaluation results are shown in Table 1 below. Note that the results below are the average of the evaluation points of the five subjects.
[0118] [Evaluation Criteria] 5: Very good. 4: Slightly better. 3: Standard. 2: Slightly inferior. 1: Very poor.
[0119] [Table 1]
[0120] Manufacturing Examples 1 to 5 The beauty essences described in Production Examples 1 to 5 were prepared in the same manner as in Example 1. The beauty essences of Production Examples 1 to 5, like the Examples, have excellent moisturizing effects, smoothness upon application, and excellent transparency and firmness of the skin after use.
[0121] [Table 2A] [Table 2B] [Industrial Applicability]
[0122] The skin external preparation of the present invention is industrially useful since it has an excellent moisturizing effect, is smooth when applied, and leaves the skin transparent and firm after use.
Claims
1. A skin topical preparation comprising the following components (A), (B), (C), (D), (E) and (F), wherein (C), (D) and (E) are encapsulated in liposomes containing (F) hydrogenated soybean phospholipid as a membrane component. (A) Niacinamide. (B) D-pantothenyl alcohol. (C) 3-O-ethyl ascorbic acid. (D) Pine bark extract. (E) At least one selected from glutathione and ceramides. (F) Hydrogenated soybean phospholipid.
2. 2. The skin external preparation according to claim 1, further comprising (G) at least one selected from the group consisting of antioxidants, moisturizing agents, anti-inflammatory agents, whitening agents, vitamins and peeling agents.
3. 3. The skin external preparation according to claim 2, wherein the (G) is one or more selected from the group consisting of bilberry leaf extract, astaxanthin, Centella asiatica leaf extract, bisglyceryl ascorbic acid, tocopherol and lactic acid.
4. The skin topical preparation according to any one of claims 1 to 3, wherein the content of (A) niacinamide is 5% by mass or more.
Citation Information
Patent Citations
Topical skin preparation for improved wrinkles
JP2021063076A
External preparation for skin
JP2022163643A
